When accessing the CDB site through an internal Novo Nordisk IP address, you will see "Your Location" as NN Internal instead of a country. This only applies to internal NN IP addresses. Thank you for your patience while the development team is upgrading this feature.

Your Location: USA

Help Join the Cause Submit Data

Bookmark and Share

Home > References

References

Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications in type 2 diabetes (UKPDS 36): prospective observational study [abstract]. BMJ. 2000 Aug 12;321(7258):412-419.

Ali S, Stone MA, Peters JL et al. The prevalence of co-morbid depression in adults with type 2 diabetes : a systematic review and meta-analysis. Diabetes Med 2006;23:1165-1173.

Amed S, Daneman D, Mahmud FH, Hamilton J. Type 2 diabetes in children and adolescents. Expert Rev Cardiovasc Ther. 2010 Mar;8(3):393-406.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009; 32(Suppl 1): S62-S67.

American Diabetes Association. Nephropathy in diabetes (position statement). Diabetes Care 2004;27(Suppl 1):S79-S83.

American Diabetes Association. Postprandial blood glucose. Diabetes Care 2001;24(4): 775-778.

American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2004;27(Suppl 1):S11-S14.

American Diabetes Association. Smoking and diabetes (Position Statement). Diabetes Care 2004;27(Suppl. 1):S74–S75.

American Diabetes Association. Standards of medical care in diabetes – 2010. Diabetes Care 2010;33(Suppl 1):S11-S61.

Anderson J et al., Obesity and disease management: effects of weight loss on comorbid conditions. Obesity Research 2001; 9 (Suppl 4): 326S–334S.

Appel, S. J., T. M. Wadas, et al. Latent autoimmune diabetes of adulthood (LADA): an often misdiagnosed type of diabetes mellitus. J Am Acad Nurse Pract. 2009; 21(3): 156-159.

Araujo MB, Mazza CS. Assessment of risk factors of poor metabolic control in type 1 diabetic children assisted in a public hospital in Argentina. Pediatr Diabetes. 2008 Oct;9(5):480-7.

Awata S, Bech P, Yoshida S, et al. Reliability and validity of the Japanese version of the World Health Organization-Five Well-Being Index in the context of detecting depression in diabetic patients. Psychiatry Clin Neurosci 2007;61(1):112-119.

Balasubramanyam A, Nalini R, et al. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev. 2008;29(3): 292-302.

Bech P, Olsen LR, Kjoler M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms : a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003;12:385-401.

Buse JB, Ginsberg HN, Bakris GL, Costa F, Eckel R, Fonseca V, et al. Primary prevention of cardiovascular disease in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2007;30:162-172.

Carroll AE, Ackermann RT, Brizendine EJ, Shen C, Marrero D. Does age at diabetes diagnosis influence long-term physical and behavioural outcomes. Diabetes Care. 2007;30(11):2859-1860.

Centers for Disease Control and Prevention. Agency for Healthcare Research and Quality. Frequently Asked Questions: Prediabetes. http://www.cdc.gov/diabetes/faq/prediabetes.htm. 2009.

Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.

Colagiuri S and Walker AE. Using an economic model of diabetes to evaluate prevention and care strategies in Australia. Health Affairs 2008; 27(1): 256-268.

Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1903-1912.

Dall T, Zhang Y, Chen Y, et al. The Economic Burden of Diabetes. Health Affairs, 29, NO. 2 (2010).

De Wit M, Pouwer F, Gemke R, Delemarre-Van De Waal H, and Snoek FJ. Validation of the WHO-5 well-being index in adolescents with type 1 diabetes. Diabetes Care 2007;30(8) :2003-2006.

Diabetes Control and Complications Trial. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14): 977-986.

Diabetes Control and Complications Trial. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care; 1996: 19(3): 195-203.

Diabetes Prevention Program Research Group. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999 Apr;22(4):623-34.

Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.

Diabetes Prevention Program Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002 Dec;25(12):2165-71.

Dornhorst A, Rossi M. Risk and prevention of type 2 diabetes with women with gestational diabetes [abstract]. Diabetes Care 1998;21(Suppl 2):B43-9.

Fagot-Campagna A, Narayan KM, Imperatore. Type 2 diabetes in children [editorial]. BMJ. 2002;322(7283): 377-378.

Fajans S, Bell GI, Polonsky K. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. NEJM. 2001;345(13):971-980.

Gillies CL, Lambert PC, Abrams KR, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008; 336: 1180.

Fishbein H, Palumbo PJ. Acute metabolic complications in diabetes. In: Diabetes in AmericaI, 2nd Edition. National Diabetes Data Group, National Institutes of Health, National Insitute of Diabetes and Digestive and Kidney Diseases. NIH Publication No. 95-1468; 1995.

Gillies CL, Lambert PC, Abrams KR, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008; 336: 1180.

Glasgow RE, Osteen VL. Evaluating diabetes education. Are we measuring the most important outcomes? Diabetes Care 1992;15(10): 1423-1432.

Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care 1999;22:1887–1898.

Hart JT. Rule of halves: implications of increasing diagnosis and reducing dropout for future workload and prescribing costs in primary care. Br J Gen Pract 1992; 42: 116.

Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms, and impaired awareness. Diabet Med. 2003;20:1016-1021.

Holman RR, Paul SK, Bethel MA, Neil HAW, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565-1576.

Hubert HB, Feinleib M, McNamara PM et al., Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5): 968-977.

International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33(3): 676-682.

International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, 2006.

International Diabetes Federation. The Diabetes Atlas. Fourth Edition. Brussels: International Diabetes Federation; 2009.

International Diabetes Federation. The Diabetes Atlas. Third Edition. Brussels: International Diabetes Federation; 2006.

International Diabetes Federation. Global guideline on pregnancy and diabetes. Brussels: International Diabetes Federation; 2009.

International Diabetes Federation. Global guidelines for type 2 diabetes. Brussels: International Diabetes Federation; 2005.

International Diabetes Federation. Guideline for management of postmeal glucose. Brussels: International Diabetes Federation; 2007

International Diabetes Federation. Position Statement – Type 2 diabetes in young people. Brussels: International Diabetes Federation; May 2008.

International Diabetes Federation. World Diabetes Day Media Kit. Brussels: International Diabetes Federation.

Jaap AJ, Jones GC, McCrimmon RJ et al. Perceived symptoms of hyperglycaemia in elderly type 2 diabetic patients treated with insulin. Diabet Med 1998; 15: 398-401.

Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab. 2002 May;15 Suppl 2:737-44. Review.

Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002 Oct;25(10):1862-8. Review.

Kroner, Z. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes? Altern Med Rev. 2009; 14(4): 373-379.

Longo-Mbenza B, Muaka MM, Mbenza G, Mbungu-Fuele S, Mabwa-Mbalanda L, Nzuzi- Babeki V, Mbadi-A-Sungu J. Risk factors of poor control of HbAic and diabetic retinopathy: Paradox with insulin therapy and high values of HDL in African diabetic patients Int J Diabetes & Metabolism. 2008; 16: 69-78.

Maahs DM, Rewers M. Editorial: Mortality and renal disease in type 1 diabetes mellitus – progress made, more to be done. J Clin Endocrinol Metab. 2006;91(10):3757-3759.

Mehers KL, Gillespie KM. The genetic basis for type 1 diabetes. British Medical Bulletin. 2008;88(1):115-129.

Michaelides C et al. Utilisation of the Changing Diabetes map as a practical tool in diabetes management: The It Just Takes 3 Project.

Monnier L, Colette C, et al. Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care. 2002;25(4): 737-741.

Monnier L, Colette C.. Target for glycemic control: concentrating on glucose. Diabetes Care. 2009;32(Suppl 2):S199-204.

Monnier L, Lapinski H, et al. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1C). Diabetes Care. 2003;26(3): 881-885.

Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676-1685.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Clin Diabetes, 2009;27(1):4–16.

National Diabetes Information Clearinghouse. Insulin resistance and prediabetes. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

Novo Nordisk. Case Studies from the Changing Diabetes Barometer Website.

Novo Nordisk. Changing Diabetes Barometer, First Report, 2007.

Novo Nordisk. Changing Diabetes Barometer International Seminar Summary Report, Oxford, 8-9 December 2008.

Pearson et al. AHA guidelines for primary prevention of cardiovascular disease and stroke:2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 2002;106(3):388-391.

Perneger TV, Brancati FL, Whelton PK, Klag MJ. End-stage renal disease attributable to diabetes mellitus. Ann Intern Med. 1994;121(12):912-918.

Ridderstråle M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol. 2009 Jan 15;297(1-2):10-7. Epub 2008 Oct 19. Review.

Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28:2130-2135.

Rosenthal MJ, Fajardo M, et al. Hospitalization and mortality of diabetes in older adults. A 3-year prospective study [abstract]. Diabetes Care. 1998;21(2): 231-235.

Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002 Mar;48(3):436-72.

Samarasinghe S, Vokes T. Diabetes insipidus. Expert Rev Anticancer Ther. 2006;6( Suppl 9): S63-74.

Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, Hu FB. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006 Jul;29(7):1585-90.

Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? J Alzheimers Dis. 2005 Feb;7(1):63-80.

Stratton IM, Adler AI, Neil HA et al., for the United Kingdom Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258): 405-412.

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26(Suppl 1):S5-S20.

The Lancet. The global challenge of diabetes. The Lancet 2008;371:1723.

The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, prediabetes and cardiovascular diseases: full text. Eur Heart J. 2007. doi: 10.1093/eurheartj/ehl261

Tuomi, T., L. C. Groop, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42(2): 359-362.

UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837-853.

UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group [abstract]. BMJ. 1998 Sep 12;317(1760):703-713.

UK Prospective Diabetes Study Group. UK prospective diabetes study 16: overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995;44(11): 1249-1258.

Watkins K and Connell CM. Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics. 2004;22.

Watson R. Health spending rising faster than GDP in most rich countries. BMJ 2006;333:60.

Waugh N, Scotland G, McNamee P, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technology Assessment 2007; 11(17).

White JR. The cost of managing diabetes mellitus: focus on the oral pharmacologic management of type II diabetes. J Managed Care Pharm 1999; 113-20.

Williamson DF, Thompson TJ, Thun M. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000; 23: 1499-1504.

Wing RR, Koeske R, Epstein LH, et al., Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987; 147: 1749–1753.

Winter WE and Silverstein JH. Molecular and genetic basis for maturity onset diabetes of youth. Curr Opin Pediatr 2000; 12(4): 388-393.

World Diabetes Foundation. Media backgrounder: diabetes in the developing world. Denmark: World Diabetes Foundation; July 2009.

Yach D, Hawkes C, Gould CL, Hofman K. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291:2616-2622.